Shared Decision Making for Advanced Renal Cell Carcinoma – Focus on Adverse Event Management of Axitinib Plus IO: A Vodcast

The above vodcast audio and infographic represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).